Ramipril — ACE inhibitor. Study the mechanism, listed uses and warnings from the US label on one sourced card.
Generic name
Ramipril
Class
ACE inhibitor
Mechanism
Ramiprilat inhibits ACE, blocking conversion of angiotensin I to angiotensin II and reducing aldosterone.
Used for
Hypertension in adults; Reduction of myocardial infarction, stroke or cardiovascular death in adults aged 55 years and older with coronary disease, prior stroke, peripheral vascular disease, or diabetes plus another labeled cardiovascular risk factor
Common side effects
Headache; Dizziness; Fatigue; Cough
Boxed warning
Fetal toxicity: discontinue as soon as pregnancy is detected.
Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.
Label date: 20260904 · For learning, not clinical decisions. US label and brand information; always consult the current source.
Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.
Mechanism: Inhibits angiotensin-converting enzyme, blocking conversion of angiotensin I to angiotensin II and suppressing the renin-angiotensin-aldosterone system.
On both cards: Common side effects — Headache; Dizziness; Cough · Warnings — Angioedema; Renal impairment · Interactions — Diuretics; NSAIDs
Only on the Lisinopril card: Used for — Hypertension in adults and children aged 6 years and older; Adjunctive therapy for heart failure; Reduction of mortality after acute myocardial infarction in hemodynamically stable patients treated within 24 hours · Common side effects — Hypotension; Chest pain · Warnings — Hyperkalemia · Interactions — Lithium
Mechanism: Benazeprilat inhibits ACE, blocking conversion of angiotensin I to angiotensin II and lowering aldosterone.
On both cards: Common side effects — Headache; Dizziness; Cough · Warnings — Angioedema; Renal impairment · Interactions — NSAIDs
Only on the Benazepril card: Used for — Hypertension in adults and children aged 6 years and older; pediatric use is not established with GFR below 30 mL/min/1.73 m² · Common side effects — Somnolence; Postural dizziness · Warnings — Hyperkalemia · Interactions — Neprilysin inhibitors (sacubitril); Lithium
Mechanism: Lisinopril inhibits ACE, lowering angiotensin II and aldosterone; hydrochlorothiazide is a thiazide diuretic.
On both cards: Common side effects — Headache; Dizziness; Fatigue; Cough
Only on the Lisinopril / Hydrochlorothiazide card: Used for — Hypertension when this fixed-dose combination is appropriate; it is not indicated for initial therapy · Common side effects — Orthostatic effects · Warnings — History of ACE inhibitor angioedema; Anuria / sulfonamide hypersensitivity; Contraindicated with sacubitril (neprilysin inhibitor) · Interactions — Diuretics (hypotension); NSAIDs incl. COX-2 inhibitors; Dual RAS blockade (ARBs, aliskiren)
An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.
Lisinopril: Drugs acting on the renin-angiotensin system can cause fetal injury and death; discontinue when pregnancy is detected.
Lisinopril / Hydrochlorothiazide: Fetal toxicity: drugs acting on the renin-angiotensin system can injure or kill the developing fetus; stop when pregnancy is detected.
Amlodipine / Benazepril: Fetal toxicity: renin-angiotensin system drugs can injure or kill the fetus; stop when pregnancy is detected.
Capsera